The first stage will collect data that will be eventually used to evaluate the efficacy and safety of the investigational hemophilia B therapy.
Take part in a survey to shape VWD Guidelines. We want to hear from people with VWD, people who care for those with VWD, or clinicians and other healthcare professionals who treat people with VWD.
This My Life, Our Future (MLOF) update highlights the projects’ potential for driving scientific and clinical breakthroughs through genotyping analysis.
Medscape has launched the latest educational activity in their “Clinical Advances in Gene Therapy for Hemophilia” series, which is presented through a collaboration between Medscape, NHF, the European Haemophilia Consortium and WFH.
The goal of this effort is to create and maintain state-of-the-art guidelines on the diagnosis and management of VWD.
The update reported on a Phase 1/2 clinical trial for the company’s investigational therapy for the treatment of patients with severe hemophilia B/factor IX (FIX) deficiency.
HTC researchers conducted this study in order to substantiate the long-held theory that individuals with hemophilia are largely protected from cardiovascular disease.
More information on how the current ACA lawsuit could affect the bleeding disorders community.
Grifols Announces Recall of One Lot of Profilnine. This recall is being conducted as a precautionary measure.
The new web portal for patients and caregivers is intended to provide timely and accurate information on targeted serious adverse events of interest for HEMLIBRA.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car